Bios Clinical Opportunity Fund, LP

CIK 00019886393 companiesFORT WORTH, TX

SEC Profile

Transactions

Companies

Filings

CIK

0001988639

Recent Transactions

50 trades

Purchase
ACTUATE THERAPEUTICS, INC.$ACTU
Warrant (Right to Buy)
2025-06-27+71,428→ 71,428 total
Purchase
ACTUATE THERAPEUTICS, INC.$ACTU
Common Stock
2025-06-27$7.00/sh+71,428→ 196,428 total
Other
IN8BIO, INC.$INAB
Series B Warrant
2025-05-02−574,241→ 0 total
Purchase
IN8BIO, INC.$INAB
Pre-Funded Warrants
2025-05-02+1,148,482→ 2,431,763 total
Other
IN8BIO, INC.$INAB
Series A Warrant
2025-05-02−574,241→ 0 total
Disposition to Issuer
IN8BIO, INC.$INAB
Series A Warrant
2024-10-04+574,241→ 0 total
Award
IN8BIO, INC.$INAB
Series A Warrant
2024-10-04+574,241→ 574,241 total
Purchase
IN8BIO, INC.$INAB
Pre-Funded Warrants
2024-10-04+709,040→ 1,283,281 total
Purchase
IN8BIO, INC.$INAB
Series C Warrant
2024-10-04+709,040→ 709,040 total
Sale
ACTUATE THERAPEUTICS, INC.$ACTU
Common Stock
2024-08-14$9.00/sh−2,324→ 131,248 total
Conversion
ACTUATE THERAPEUTICS, INC.$ACTU
Common Stock
2024-08-14+309,589→ 309,589 total
Conversion
ACTUATE THERAPEUTICS, INC.$ACTU
Common Stock
2024-08-14+884,427→ 884,427 total
Purchase
ACTUATE THERAPEUTICS, INC.$ACTU
Common Stock
2024-08-14$8.00/sh+125,000→ 125,000 total
Conversion
ACTUATE THERAPEUTICS, INC.$ACTU
Common Stock
2024-08-14+176,499→ 638,572 total
Conversion
ACTUATE THERAPEUTICS, INC.$ACTU
Common Stock
2024-08-14+525,797→ 525,797 total
Conversion
ACTUATE THERAPEUTICS, INC.$ACTU
Series B-2 Redeemable Convertible Preferred Stock
2024-08-14−147,047→ 0 total
Conversion
ACTUATE THERAPEUTICS, INC.$ACTU
Series B-4 Redeemable Convertible Preferred Stock
2024-08-14−326,547→ 0 total
Exercise of In-Money
ACTUATE THERAPEUTICS, INC.$ACTU
Common Stock
2024-08-14$5.27/sh+3,528→ 133,572 total
Conversion
ACTUATE THERAPEUTICS, INC.$ACTU
Series B-1 Redeemable Convertible Preferred Stock
2024-08-14−141,457→ 0 total
Conversion
ACTUATE THERAPEUTICS, INC.$ACTU
Series B-2 Redeemable Convertible Preferred Stock
2024-08-14−54,032→ 0 total
Conversion
ACTUATE THERAPEUTICS, INC.$ACTU
Series C Redeemable Convertible Preferred Stock
2024-08-14−74,202→ 0 total
Conversion
ACTUATE THERAPEUTICS, INC.$ACTU
Series C Redeemable Convertible Preferred Stock
2024-08-14−484,638→ 0 total
Conversion
ACTUATE THERAPEUTICS, INC.$ACTU
Common Stock
2024-08-14+462,073→ 462,073 total
Conversion
ACTUATE THERAPEUTICS, INC.$ACTU
Common Stock
2024-08-14+153,702→ 153,702 total
Conversion
ACTUATE THERAPEUTICS, INC.$ACTU
Common Stock
2024-08-14+54,032→ 195,489 total
Conversion
ACTUATE THERAPEUTICS, INC.$ACTU
Common Stock
2024-08-14+147,047→ 300,749 total
Conversion
ACTUATE THERAPEUTICS, INC.$ACTU
Common Stock
2024-08-14+101,900→ 297,389 total
Conversion
ACTUATE THERAPEUTICS, INC.$ACTU
Common Stock
2024-08-14+44,559→ 130,044 total
Conversion
ACTUATE THERAPEUTICS, INC.$ACTU
Common Stock
2024-08-14+78,267→ 404,814 total
Exercise of In-Money
ACTUATE THERAPEUTICS, INC.$ACTU
Common Stock
2024-08-14$5.27/sh+26,355→ 997,794 total
Sale
ACTUATE THERAPEUTICS, INC.$ACTU
Common Stock
2024-08-14$9.00/sh−17,361→ 980,433 total
Conversion
ACTUATE THERAPEUTICS, INC.$ACTU
Common Stock
2024-08-14+307,538→ 307,538 total
Conversion
ACTUATE THERAPEUTICS, INC.$ACTU
Common Stock
2024-08-14+573,394→ 573,394 total
Exercise of In-Money
ACTUATE THERAPEUTICS, INC.$ACTU
Warrant (Right to Buy)
2024-08-14−3,528→ 0 total
Conversion
ACTUATE THERAPEUTICS, INC.$ACTU
Common Stock
2024-08-14+332,867→ 971,439 total
Conversion
ACTUATE THERAPEUTICS, INC.$ACTU
Common Stock
2024-08-14+2,022,029→ 2,022,029 total
Conversion
ACTUATE THERAPEUTICS, INC.$ACTU
Common Stock
2024-08-14+326,547→ 326,547 total
Conversion
ACTUATE THERAPEUTICS, INC.$ACTU
Common Stock
2024-08-14+74,202→ 383,791 total
Conversion
ACTUATE THERAPEUTICS, INC.$ACTU
Common Stock
2024-08-14+484,638→ 2,506,667 total
Conversion
ACTUATE THERAPEUTICS, INC.$ACTU
Series B-1 Redeemable Convertible Preferred Stock
2024-08-14−61,857→ 0 total
Conversion
ACTUATE THERAPEUTICS, INC.$ACTU
Series B-1 Redeemable Convertible Preferred Stock
2024-08-14−153,702→ 0 total
Conversion
ACTUATE THERAPEUTICS, INC.$ACTU
Common Stock
2024-08-14+141,457→ 141,457 total
Conversion
ACTUATE THERAPEUTICS, INC.$ACTU
Series B-4 Redeemable Convertible Preferred Stock
2024-08-14−309,589→ 0 total
Conversion
ACTUATE THERAPEUTICS, INC.$ACTU
Series A Redeemable Convertible Preferred Stock
2024-08-14−525,797→ 0 total
Conversion
ACTUATE THERAPEUTICS, INC.$ACTU
Series A Redeemable Convertible Preferred Stock
2024-08-14−307,538→ 0 total
Conversion
ACTUATE THERAPEUTICS, INC.$ACTU
Series B-1 Redeemable Convertible Preferred Stock
2024-08-14−462,073→ 0 total
Conversion
ACTUATE THERAPEUTICS, INC.$ACTU
Series C Redeemable Convertible Preferred Stock
2024-08-14−573,394→ 0 total
Conversion
ACTUATE THERAPEUTICS, INC.$ACTU
Series B-4 Redeemable Convertible Preferred Stock
2024-08-14−2,022,029→ 0 total
Exercise of In-Money
ACTUATE THERAPEUTICS, INC.$ACTU
Warrant (Right to Buy)
2024-08-14−26,355→ 0 total
Conversion
ACTUATE THERAPEUTICS, INC.$ACTU
Series B-2 Redeemable Convertible Preferred Stock
2024-08-14−176,499→ 0 total

Companies

Recent Filings

Address

C/O BIOS EQUITY PARTNERS 1751 RIVER RUN SUITE 400

FORT WORTH, TX, 76107

View on SEC.gov